A Study of Pimavanserin in Pediatric Subjects with Autism Spectrum Disorder

  • Ages 5-17
  • Diagnosis of Autism Spectrum Disorder
  • Verbal and able to swallow a capsule
  • If you have history of medical issues such as seizures, blood disorders, or other major health conditions you may not qualify for this trial
  • Open-label study to follow

Learn More About Participating in a Study

  • This field is for validation purposes and should be left unchanged.